Medicure . undefined Employee Directory
Pharmaceutical ManufacturingManitoba, Canada201-500 Employees
Medicure is a pharmaceutical manufacturing company based in Winnipeg, Manitoba, Canada, with 201-500 employees, focused on the development and commercialization of cardiovascular medicines for the United States market. The company markets and distributes AGGRASTAT injections (tirofiban hydrochloride) for hospital use in cardiac catheterization labs, and ZYPITAMAG tablets (pitavastatin), which was FDA approved in 2017. In 2020 Medicure acquired Marley Drug, a North Carolina pharmacy, expanding patient access to medications including ZYPITAMAG tablets, and the Pharmacy Business Segment now includes Marley Drug along with two pharmacies purchased in 2025, Gateway Medical Pharmacy and West Olympia Pharmacy. Medicure invests in research and development, including a Phase 3 trial for MC-1 to treat PNPO deficiency, reflecting ongoing development beyond its marketed products. The company has publicly reported quarterly results in 2026, indicating ongoing operations and financial activity.